首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1391967

細胞外基質市場：依成分類型、應用、來源、最終用途、產品類型、技術、治療領域、功能、生物材料材料類型、最終用途行業、地區

Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

出版日期: 2023年11月01日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細胞外基質市場規模預計將從 2023 年的 3,790 萬美元增至 2030 年的 6,410 萬美元，預測期內複合年成長率為 7.8%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	3790萬美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	7.80%	2030年市場規模預測	6410萬美元

圖 1. 2023 年細胞外基質市場佔有率(%)（依地區）

細胞外基質（ECM）是指由蛋白質和碳水化合物組成的複雜網路，為組織和器官內的細胞提供結構支撐。它在控制細胞行為，包括細胞黏合、遷移、增殖和分化方面發揮重要作用。 ECM 也作為生長因子和細胞激素的儲存庫，影響各種細胞過程。由於慢性傷口數量的增加、人口高齡化和道路事故發生率的增加，預計未來幾年全球細胞外基質市場規模將顯著成長。源自人類/動物組織的細胞外基質可作為細胞遷移、增殖和組織組織的支架。透過刺激細胞增生、新血管和組織重塑來促進創傷治療。 ECM 技術旨在重現適當的組織再生和功能所需的複雜結構和生化訊號。慢性傷口癒合方面令人鼓舞的臨床結果以及對微創治療方案的日益偏好可能會推動醫療保健產業對 ECM 產品的需求。

市場動態：

然而，市場面臨諸如基於ECM的療法的高成本、嚴格的監管要求和限制性報銷政策等課題。基於 ECM 的治療方法的高成本是市場成長的主要障礙，限制了更多患者群體的使用。此外，某些地區對ECM產品核准的嚴格監管要求和有限的報銷政策也阻礙了市場擴張。

此外，隨著再生醫學需求的增加，擴大新興市場的產品系列可能會開闢新的市場成長途徑。

總之，全球細胞外基質市場是由慢性病盛行率增加和再生醫學需求增加等因素所推動的。然而，需要解決高成本和監管要求等課題，同時需要利用新興地區的技術創新和市場拓展等機會。

本研究的主要特點

本報告對全球細胞外基質市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和複合年成長率。
它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據以下參數（例如公司亮點、產品系列、主要亮點、財務實績和策略）來介紹全球虛擬醫療服務市場的主要企業。
該報告的見解使公司行銷人員和負責人能夠就未來的產品發布、經營團隊升級、市場擴張和行銷策略做出明智的資訊。
全球細胞外基質市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球細胞外基質市場的各種策略矩陣，將促進相關人員的決策。

Thermo Fisher Scientific
DSM
Acelity（KCI Concepts）
Corning Incorporated
Baxter
FUJIFILM Holdings Corporation
Integra LifeSciences
CellSystems Biotechnologie Vertrieb GmbH
Biotime, Inc.
Trevigen, Inc.
Advanced BioMatrix
Collagen Matrix, Inc.
Merck KGaA
VWR International LLC
REPROCELL USA Inc.
BioLamina AB
Matricel GmbH
Tissue Regenix
Admedus
MIMETAS

第17章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6171

The extracellular matrix market size is expected to reach US$ 64.1 Mn by 2030, from US$ 37.9 Mn in 2023, at a CAGR of 7.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 37.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.80%	2030 Value Projection:	US$ 64.1 Mn

Figure 1. Extracellular Matrix Market Share (%), By Region, 2023

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes. The global extracellular matrix market size is expected to grow significantly in the coming years due to rising incidences of chronic wounds, increasing aging population and growing incidence of road accidents. Extracellular matrix derived from human/animal tissues acts as a scaffold for cellular migration, proliferation and tissue organization. It promotes wound healing by stimulating cell proliferation, neovascularization and tissue remodeling. ECM technologies aim to recreate the complex structural and biochemical signals required for proper tissue regeneration and function. Promising clinical results in healing chronic wounds, combined with increasing preference for minimally invasive treatment options will boost demand for ECM products in the healthcare industry.

Market Dynamics:

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global virtual health service market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Extracellular Matrix Market Segmentation:

By Component Type
- Proteins
- Glycoproteins
- Proteoglycans
- Other ECM molecules
By Application:
- Regenerative Medicine
- Tissue Engineering
- Wound Healing
- Drug Delivery
- Others
By Source:
- Animal-Derived ECM
- Human-Derived ECM
- Synthetic ECM
By End-User:
- Research Institutes and Academic Centers
- Biotechnology and Pharmaceutical Companies
- Hospitals and Clinics
By Product Type:
- Hydrogels
- Scaffolds
- Decellularized ECM
- ECM Analogs
- Others
By Technology:
- 3D Bioprinting
- Nanotechnology
- Cell Culture Techniques
- Genetic Engineering
- Others
By Therapeutic Area:
- Orthopedics
- Dermatology
- Cardiology
- Neurology
- Oncology
- Others
By Function:
- Structural Support
- Cellular Communication
- Cell Adhesion
- Signal Transduction
By Biomaterial Type:
- Natural ECM
- Synthetic ECM
By End-Use Industry:
- Healthcare
- Research and Development
- Cosmetics
- Pharmaceuticals
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top companies in Extracellular Matrix Market
- Thermo Fisher Scientific
- DSM
- Acelity (KCI Concepts)
- Corning Incorporated
- Baxter
- FUJIFILM Holdings Corporation
- Integra LifeSciences
- CellSystems Biotechnologie Vertrieb GmbH
- Biotime, Inc.
- Trevigen, Inc.
- Advanced BioMatrix
- Collagen Matrix, Inc.
- Merck KGaA
- VWR International LLC
- REPROCELL USA Inc.
- BioLamina AB
- Matricel GmbH
- Tissue Regenix
- Admedus
- MIMETAS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Global Extracellular Matrix, By Component Type
- Market Global Extracellular Matrix, By Application
- Market Global Extracellular Matrix, By Source
- Market Global Extracellular Matrix, By End-User
- Market Global Extracellular Matrix, By Product Type
- Market Global Extracellular Matrix, By Technology
- Market Global Extracellular Matrix, By Therapeutic Area
- Market Global Extracellular Matrix, By Function
- Market Global Extracellular Matrix, By Biomaterial Type
- Market Global Extracellular Matrix, By End-Use Industry
- Market Global Extracellular Matrix, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
The increasing prevalence of chronic diseases
- Restraints
High cost of ECM-based therapies
- Opportunities
Development of innovative ECM-based products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Extracellular Matrix Market , By Component Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Glycoproteins
Proteoglycans
Other ECM molecules

6. Global Extracellular Matrix Market , By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Tissue Engineering
Wound Healing
Drug Delivery
Cancer Research
Others

7. Global Extracellular Matrix Market , By Source, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Animal-Derived ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Human-Derived ECM
Synthetic ECM

8. Global Extracellular Matrix Market , By End-User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Biotechnology and Pharmaceutical Companies
Hospitals and Clinics

9. Global Extracellular Matrix Market , By Product Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hydrogels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Scaffolds
Decellularized ECM
ECM Analogs
Others

10. Global Extracellular Matrix Market , By Technology, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
3D Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Nanotechnology
Cell Culture Techniques
Genetic Engineering
Others

11. Global Extracellular Matrix Market , By Therapeutic Area, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Dermatology
Cardiology
Neurology
Oncology
Others

12. Global Extracellular Matrix Market , By Function, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Structural Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Cellular Communication
Cell Adhesion
Signal Transduction

13. Global Extracellular Matrix Market , By Biomaterial Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Natural ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Synthetic ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

14. Global Extracellular Matrix Market , By End-Use Industry, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Research and Development
Cosmetics
Pharmaceuticals
Others

15. Global Extracellular Matrix Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

16. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DSM
Acelity (KCI Concepts)
Corning Incorporated
Baxter
FUJIFILM Holdings Corporation
Integra LifeSciences
CellSystems Biotechnologie Vertrieb GmbH
Biotime, Inc.
Trevigen, Inc.
Advanced BioMatrix
Collagen Matrix, Inc.
Merck KGaA
VWR International LLC
REPROCELL USA Inc.
BioLamina AB
Matricel GmbH
Tissue Regenix
Admedus
MIMETAS
Analyst Views